GLENMARK PHARMACEUTICALS
Back to Income Statement
|
GLENMARK PHARMACEUTICALS Last 5 Year Profit After Tax History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Profit After Tax | ₹-1,831 Cr | ₹-90 Cr | ₹994 Cr | ₹970 Cr | ₹776 Cr |
What is the latest Profit After Tax of GLENMARK PHARMACEUTICALS ?
| Year | Profit After Tax |
|---|---|
| Mar2025 | ₹-1,831 Cr |
| Mar2024 | ₹-90 Cr |
| Mar2023 | ₹994 Cr |
| Mar2022 | ₹970 Cr |
| Mar2021 | ₹776 Cr |
How is Profit After Tax of GLENMARK PHARMACEUTICALS Trending?
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2025 | ₹-1,831 Cr | Negative | |
| Mar2024 | ₹-90 Cr | Negative | |
| Mar2023 | ₹994 Cr | 2.43 | |
| Mar2022 | ₹970 Cr | 25.02 | |
| Mar2021 | ₹776 Cr | - | |
Compare Profit After Tax of peers of GLENMARK PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLENMARK PHARMACEUTICALS | ₹56,991.7 Cr | 3.3% | 7.3% | 32.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹416,884.0 Cr | -0.5% | -1.9% | -3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹172,442.0 Cr | 1.8% | 1.3% | 10.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,770.0 Cr | 1.3% | 2.7% | 10% | Stock Analytics | |
| CIPLA | ₹120,871.0 Cr | -0.2% | -0.7% | 1.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,693.0 Cr | -1% | 2.5% | -4.4% | Stock Analytics | |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLENMARK PHARMACEUTICALS | 3.3% |
7.3% |
32.7% |
| SENSEX | 1% |
0.6% |
7.8% |
You may also like the below Video Courses